80 related articles for article (PubMed ID: 38616962)
1. The discovery of novel imidazo[1,2-
Song Q; Zhang Q; Fan X; Kayaat F; Lv R; Li J; Wang Y
Org Biomol Chem; 2024 Jun; ():. PubMed ID: 38869445
[TBL] [Abstract][Full Text] [Related]
2. QM/MM simulations of EFGR with afatinib reveal the role of the
Ma S; Patel H; Peeples CA; Shen J
bioRxiv; 2024 May; ():. PubMed ID: 38766221
[TBL] [Abstract][Full Text] [Related]
3. KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?
Nagasaka M; Li Y; Sukari A; Ou SI; Al-Hallak MN; Azmi AS
Cancer Treat Rev; 2020 Mar; 84():101974. PubMed ID: 32014824
[TBL] [Abstract][Full Text] [Related]
4. Covalent inhibitor targets KRas
Li HY; Qi WL; Wang YX; Meng LH
Genes Dis; 2023 Mar; 10(2):403-414. PubMed ID: 37223497
[No Abstract] [Full Text] [Related]
5. Multiscale calculations reveal new insights into the reaction mechanism between KRAS
Yan X; Qu C; Li Q; Zhu L; Tong HHY; Liu H; Ouyang Q; Yao X
Comput Struct Biotechnol J; 2024 Dec; 23():1408-1417. PubMed ID: 38616962
[TBL] [Abstract][Full Text] [Related]
6. Proof of concept for poor inhibitor binding and efficient formation of covalent adducts of KRAS
Khrenova MG; Kulakova AM; Nemukhin AV
Org Biomol Chem; 2020 Apr; 18(16):3069-3081. PubMed ID: 32101243
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel quinazoline-based covalent inhibitors of KRAS G12C with various cysteine-targeting warheads as potential anticancer agents.
Li L; Zhao H; Liao H; Chen J; Liu J; Chen J
Bioorg Chem; 2021 May; 110():104825. PubMed ID: 33774492
[TBL] [Abstract][Full Text] [Related]
8. High-level QM/MM calculations support the concerted mechanism for Michael addition and covalent complex formation in thymidylate synthase.
Kaiyawet N; Lonsdale R; Rungrotmongkol T; Mulholland AJ; Hannongbua S
J Chem Theory Comput; 2015 Feb; 11(2):713-22. PubMed ID: 26579604
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition.
Huynh MV; Parsonage D; Forshaw TE; Chirasani VR; Hobbs GA; Wu H; Lee J; Furdui CM; Poole LB; Campbell SL
J Biol Chem; 2022 Aug; 298(8):102186. PubMed ID: 35753348
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophoric analogs of sotorasib-entrapped KRAS G12C in its inactive GDP-bound conformation: covalent docking and molecular dynamics investigations.
Oyedele AK; Ogunlana AT; Boyenle ID; Ibrahim NO; Gbadebo IO; Owolabi NA; Ayoola AM; Francis AC; Eyinade OH; Adelusi TI
Mol Divers; 2023 Aug; 27(4):1795-1807. PubMed ID: 36271195
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for inhibition of a GH116 β-glucosidase and its missense mutants by GBA2 inhibitors: Crystallographic and quantum chemical study.
Meelua W; Thinkumrob N; Saparpakorn P; Pengthaisong S; Hannongbua S; Ketudat Cairns JR; Jitonnom J
Chem Biol Interact; 2023 Oct; 384():110717. PubMed ID: 37726065
[TBL] [Abstract][Full Text] [Related]
12. Multiscale QM/MM Simulations Identify the Roles of Asp239 and 1-OH···Nucleophile in Transition State Stabilization in
Meelua W; Wanjai T; Thinkumrob N; Friedman R; Jitonnom J
J Chem Inf Model; 2023 Aug; 63(15):4827-4838. PubMed ID: 37503869
[No Abstract] [Full Text] [Related]
13. Assessment of Reversibility for Covalent Cysteine Protease Inhibitors Using Quantum Mechanics/Molecular Mechanics Free Energy Surfaces.
Dos Santos AM; Oliveira ARS; da Costa CHS; Kenny PW; Montanari CA; Varela JJG; Lameira J
J Chem Inf Model; 2022 Sep; 62(17):4083-4094. PubMed ID: 36044342
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Insights into Enzyme Catalysis from Explaining Machine-Learned Quantum Mechanical and Molecular Mechanical Minimum Energy Pathways.
Song Z; Trozzi F; Tian H; Yin C; Tao P
ACS Phys Chem Au; 2022 Jul; 2(4):316-330. PubMed ID: 35936506
[TBL] [Abstract][Full Text] [Related]
15. Nitrogen-Centered Nucleophile Catalyzed Thiol-Vinylsulfone Addition, Another Thiol-ene "Click" Reaction.
Xi W; Wang C; Kloxin CJ; Bowman CN
ACS Macro Lett; 2012 Jul; 1(7):811-814. PubMed ID: 35607123
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
